Key Allegations Against Novo Nordisk The crux of these lawsuits lies in allegations that Novo Nordisk, the manufacturer of Ozempic, was remiss in warning users about potential severe side effects, which include: Gastroparesis Concerns : Often termed stomach paralysis lawsuits, these claims assert that users were not adequately warned about the risk of delayed stomach emptying, a condition known as gastroparesis
For patients who have addressed those two questions - who understand the compounded versus FDA-approved distinction, have confirmed current pricing and terms directly with WellMedr, and want a full-service GLP-1 care model rather than a prescription-and-ship approach - WellMedr is a program worth evaluating through its licensed clinician intake process
Stopping Medication Too Soon The issue: Discontinuing semaglutide prematurely can lead to weight regain and prevent long-term success
Safety Concerns with Combining GLP-1 and GIP Agonists Side effects of GLP-1 receptor agonists include nausea, vomiting, constipation, and diarrhea, particularly during dose escalation
Avoid high-fat, spicy, and acidic foods, which irritate the stomach lining and intensify nausea symptoms during the adjustment phase
pylori infection, peptic ulcers, GERD, or other gastrointestinal conditions